Effects of CPAP on Cognitive Fog in Post-COVID Patients with Obstructive Sleep Apnea

Clicks: 5
ID: 339930
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #67 of 67 articles by views in SLEEP Advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Study objectives To evaluate whether treatment of comorbid OSA with CPAP improves cognitive fog in patients with post–COVID syndrome. Methods In this prospective, open-label pilot trial, 20 patients with post–COVID syndrome, self-reported cognitive fog, and comorbid OSA completed standardized neurocognitive assessments before and 4±2 weeks after CPAP initiation. The primary outcome was the Montreal Cognitive Assessment (MoCA) and secondary outcome was the PROMIS Cognitive Function T-score. Additional outcomes included measures of executive function (Digit Span Backwards, Trail Making Test B, Stroop Color-Word), processing speed (Digit Symbol Substitution), episodic memory (Benson Complex Delayed Recall), verbal fluency, and vigilance (Psychomotor Vigilance Test). Paired t-tests assessed response to CPAP and linear regression examined dose–response relationships with CPAP use. Results Mean age was 48.7±14.2 years, 55% women, 15% Black, median AHI was 12 [IQR 10–30] events/hour, median time since COVID-19 infection was 29 [IQR 17–44] months, and mean CPAP use was 6.2±2.4 hours/night. Among 17/20 participants who completed follow-up, no significant improvement was observed in MoCA. However, PROMIS Cognitive Function T-score improved by 8.0±2.2 points (43.1±1.7 vs 35.1±1.5; Cohen’s d=-1.0, p<0.01). Greater CPAP use was associated with reduced cognitive symptoms. Significant improvements were observed on Stroop Color-Word, Digit Symbol Substitution, Benson Complex Delayed Recall, and Psychomotor Vigilance Test, whereas Digit Span Backwards, Trail Making Test B, and verbal fluency performance did not improve. Conclusions Our findings suggest that screening and treating comorbid OSA with CPAP in patients with post–COVID syndrome may yield large improvements in cognitive fog symptoms.
Reference Key
openalex_W7232448096 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal SLEEP Advances
Year 2026
DOI
10.1093/sleepadvances/zpag124
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.